Venmax Drugs & Pharmaceuticals
VENMAXBSE

Venmax Drugs & Pharmaceuticals

₹26.740.19 (0.72%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
24.01
Today’s high
27.90
52 week low
19.01
52 week high
36.96
Open price
27.90
Previous close
26.55
Live volume
1,450
Lower circuit
21.24
Upper circuit
31.86

Fundamentals

Market Cap
₹23Cr
ROE
4.02%
P/E Ratio(TTM)
26.82
EPS(TTM)
0.99
P/B Ratio
2.30
Dividend Yield
0.00%
Industry P/E
40.44
Book Value
11.53
Debt to Equity
0.36
Face Value
10

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About

Venmax is primarily engaged in the manufacturing and trading of pharmaceutical formulations, drug intermediates, and Active Pharmaceutical Ingredients (APIs). The company is currently developing oncology products and is in the planning stages of establishing a new manufacturing unit with a cGMP facility at the Hyderabad Pharma Cluster to target export markets.;
CEO/MD
Mr. Venkata Rao Sadhanala
Founded in
1988
BSE symbol
531015

Shareholding Pattern

Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Retail And Others
86.20%
Promoters
13.80%

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
Innova CaptabINNOVACAP
₹722.60
+12.20 (1.72%)
L
    H
    4,075.5630.783.99
    ₹422.70
    +2.45 (0.58%)
    L
      H
      3,929.1743.845.39
      ₹324.50
      -3.52 (1.07%)
      L
        H
        3,571.3474.6613.51
        Aarti DrugsAARTIDRUGS
        ₹370.45
        +3.50 (0.95%)
        L
          H
          3,344.5916.522.28
          2026
          7
          Feb
          Quarterly Result
          Release date
          2025
          12
          Nov
          Quarterly Result
          Release date
          23
          Jul
          Quarterly Result
          Release date
          Events calendar
          View upcoming events in other stocks